Answers are grounded in this paper and cite their sources.
Delayed diagnosis remains a major obstacle to initiating effective therapy prior to the development of end-stage organ failure. Trials of antibodies to deplete deposited fibrils are underway.
No takes yet. Share an insight, caveat, or question.
Morie A. Gertz (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: